Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04127006 · ClinicalTrials.gov registry record
Rate of Progression in EYS Related Retinal Degeneration
A clinical trial of Retinitis Pigmentosa and Eye Diseases, sponsored by Jaeb Center for Health Research.
- Active
- Registry status
- 103
- Enrollment target
- 19
- Study locations
NCT04127006 is a study of Retinitis Pigmentosa and Eye Diseases that is active but no longer recruiting, run by Jaeb Center for Health Research. The registered enrollment target is 103 participants, below the 259-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (60% lower). The trial reports 19 study locations across 13 states.
The verdict
NCT04127006, a study of Retinitis Pigmentosa and Eye Diseases, is active but no longer recruiting, sponsored by Jaeb Center for Health Research.
- ACTIVE NOT RECRUITING
- Registry status
- 103 participants
- Enrollment target
- 19
- Study locations
Study Summary
The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with EYS mutations in order to accelerate the development of outcome measures for clinical trials.
Conditions Studied
Study Locations (19)
Other
- Hospital for Sick Children - Toronto
- Helsinki University Hospital - Helsinki
- Centre hospitalier National d'Ophtalmologie des Quinze-Vingts - Paris
- University of Tubingen - Tübingen
- Hadassah Medical Center - Jerusalem
- Radboud University - Nijmegen
Florida
- Vitreo-Retinal Associates - Gainesville
- University of Miami: Neuro-ophthalmology Department - Miami
California
- University of California, San Francisco - San Francisco
Colorado
- Colorado Retina Associates - Denver
Georgia
- Emory Eye Center - Atlanta
Maryland
- Wilmer Eye Institute at Johns Hopkins - Baltimore
Massachusetts
- Massachusetts Eye and Ear - Boston
Michigan
- Kellogg Eye Center, University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2026-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04127006
The ClinicalTrials.gov registry entry for NCT04127006 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (60% lower). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 0 interventions.
NCT04127006 reports 19 study locations spanning 13 distinct geographic areas - top geographies include Other, Florida, California.
Frequently Asked Questions
What is clinical trial NCT04127006 about?
NCT04127006 is a clinical study titled "Rate of Progression in EYS Related Retinal Degeneration". The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with EYS mutations in order to accelerate the development of outcome measures for clinical trials.
What is the current status of trial NCT04127006?
This trial is currently active not recruiting. The enrollment target is 103 participants. The study started on 2020-02-25. Estimated completion is 2026-04-01.
What conditions does trial NCT04127006 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa, Eye Diseases.
Who is sponsoring clinical trial NCT04127006?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04127006 being conducted?
This trial has 19 study locations across California, Colorado, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promising ROd-cone DYstrophy Gene therapY
RECRUITING · Phase 1
-
High Resolution Retinal Imaging
RECRUITING
-
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
RECRUITING · Phase 2
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
Retinal Imaging in Patients With Inherited Retinal Degenerations
RECRUITING
-
Cell Collection to Study Eye Diseases
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.